Young survivors of severe brain hemorrhage have an elevated risk of suicide: more attention needs to be paid to psychological rehabilitation
A nationwide Finnish study conducted at HUS Neurosurgery revealed that survivors of life-threatening brain hemorrhage have a significantly elevated risk of suicide. The risk is especially higher in patients under the age of 40 and those with a recent brain hemorrhage.

Subarachnoid hemorrhage (SAH) is a life-threatening cerebrovascular disorder where the rupture of a bulging blood vessel, called an aneurysm, causes bleeding in the brain. Today, more and more patients with SAH survive and make a good physical recovery, but at least one third of all affected patients suffer from depression and anxiety.
A study by researchers from HUS and University of Helsinki published in the journal Neurology investigated the risk of suicide in Finland over two decades among patients who survived SAH for at least one month after their illness. The study included more than 5,700 patients.
The results show that SAH survivors have about 75 percent higher risk of suicide in comparison with the general Finnish population of the same age and sex. A particularly elevated risk, almost four times higher, was observed in young survivors aged 15 to 39. Moreover, the first year post-SAH appeared to be a particularly high-risk period for suicide.
Physical recovery alone is not enough
“It is worrying that as many as 14 percent of deaths among young SAH survivors were due to suicide. The increased risk of suicide seems to be higher following a SAH than after other cerebrovascular disorders, namely cerebral infarction and intracerebral hemorrhage,” says Aleksanteri Asikainen, Bachelor of Medicine and Ph.D. student from the University of Helsinki.
The link between SAH and elevated risk of suicide is thought to be due to a sudden decline in physical and cognitive function, which increases psychological distress and exacerbates existing mental health disorders. In young, often healthy, individuals, the consequences of SAH are likely to be more evident in everyday life than in the general population.
The other members of the research group, HUS Neurosurgeon and Associate Professor Miikka Korja, Professor of Genetic Epidemiology from the University of Helsinki Jaakko Kaprio, and Physician Specializing in Neurosurgery at HUS and Associate Professor Ilari Rautalin stress the need for further research to more precisely identify risk factors that influence the suicide risk and to develop rehabilitation measures to support patients.
“Our study underlines that physical recovery alone is not enough. It is more important than ever to identify patients' psychological support needs and to intervene early in mental health issues to prevent consequences that can significantly reduce quality of life and even be life-threatening," says Rautalin, the senior author of the article.
Research article: Asikainen A, Korja M, Kaprio J, Rautalin I. Risk of Suicide After Aneurysmal Subarachnoid Hemorrhage: A Nationwide Study
The study was published online in the journal Neurology on January 15, 2025.
In a university hospital, research is part of the treatment: we continuously evaluate and develop care based on scientific research evidence and patient experience. At HUS, we conduct close research collaboration with the Faculty of Medicine at the University of Helsinki. We publish approximately 2,400 peer-reviewed research articles) annually, which we highlight in our newsfeed.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Bachelor of Medicine, Ph.D. Student Aleksanteri Asikainen,
HUS Neurocenter, Neurosurgery and University of Helsinki
aleksanteri.asikainen@helsinki.fi
Specialist in Neurosurgery, Associate Professor Miikka Korja
HUS Neurocenter, Neurosurgery and University of Helsinki
miikka.korja@hus.fi
Specializing Physician in Neurosurgery, Associate Professor Ilari Rautalin,
HUS Neurocenter, Neurosurgery and University of Helsinki
ilari.rautalin@helsinki.fi
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Gips räcker vid frakturer på mediala humerusepikondylen vid armbågsleden hos barn9.9.2025 09:55:56 EEST | Pressmeddelande
I en nyligen publicerad studie framgick det att gipsning som behandling vid frakturer på mediala humerusepikondylen hos barn är en lika effektiv behandlingsform som operation. De resultat som man nu fått stöder gipsbehandling som primär behandlingsform och behandlingen kan förenhetligas på riksnivå.
Kipsi riittää lasten kyynärnivelen koukistajalisäkkeen murtumissa9.9.2025 09:55:56 EEST | Tiedote
Juuri julkaistussa tutkimuksessa selvisi, että lasten kyynärnivelen koukistajalisäkkeen murtumien hoidossa kipsaus on yhtä tehokas hoitomuoto kuin leikkaus. Nyt saadut tulokset tukevat kipsihoidon käyttöä ensisijaisena hoitomuotona, ja hoitoa voidaan yhtenäistää kansallisesti.
Den nyaste ekonomiska prognosen för hela 2025: HUS är på väg att uppnå sina ekonomiska mål för 20258.9.2025 12:09:48 EEST | Pressmeddelande
HUS-sammanslutningens styrelse behandlade på sitt möte verksamheten och ekonomin i januari–juli samt den nyaste årsprognosen för hela 2025. HUS-sammanslutningens operativa resultat beräknas uppvisa ett överskott på 0,1 miljoner euro. Sammanslutningens styrelse fastställde också investeringsplanen och investeringsprogrammet för de kommande åren.
Koko vuoden 2025 uusin talousennuste: HUS pääsemässä vuonna 2025 taloudellisiin tavoitteisiinsa8.9.2025 12:09:48 EEST | Tiedote
HUSin yhtymähallitus käsitteli kokouksessaan tammi–heinäkuun taloutta sekä uusinta koko vuoden 2025 vuosiennustetta. HUS-yhtymän operatiivisen tuloksen ennustetaan päätyvän 0,1 miljoonaa euroa ylijäämäiseksi. Yhtymähallitus vahvisti myös tulevien vuosien investointisuunnitelman ja -ohjelman.
Förebyggande av RS-virusinfektion hos spädbarn inleds på HUS sjukhus3.9.2025 14:17:24 EEST | Pressmeddelande
RS-virus (respiratory syncytial virus, RSV) är den vanligaste orsaken till luftvägsinfektioner som kräver sjukhusvård hos små barn. HUS erbjuder en antikropp som utvecklats mot RS-virus, det vill säga nirsevimab åt nyfödda och barn under ett år som hör till riskgrupperna.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom